Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer.
CONCLUSIONS: Single fraction, focal, multimodal image guided salvage HDR brachytherapy for recurrent prostate cancer is a feasible therapy for selected patients with single lesions. This approach has to be evaluated in larger clinical trials.
PMID: 27504134 [PubMed]
Source: Journal of Contemporary Brachytherapy - Category: Cancer & Oncology Tags: J Contemp Brachytherapy Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Clinical Trials | CT Scan | External Beam Therapy | MRI Scan | PET Scan | Prostate Cancer | Radiation Therapy | Toxicology | Ultrasound